<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma activity of myeloperoxidase (MPO), malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) and <z:chebi fb="0" ids="32585">4-hydroxynonenal</z:chebi> (HNE) was measured prior to any treatment in 50 consecutive <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, as well as in 14 healthy control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Mann-Whitney-Wilcoxon test for unpaired data showed greater values of MPO (p &lt; 0.01), <z:chebi fb="14" ids="32506">MDA</z:chebi> (p &lt; 0.01) and HNE (p &lt; 0.05) in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients compared with controls </plain></SENT>
<SENT sid="2" pm="."><plain>Considering as covariates the level of consciousness (GCS &lt; 9 vs &gt; or = 9), possible sources of emboli (yes vs no), leukocyte count (&lt; 10 x 10(9)/1 vs &gt; or = 10 x 10(9)/1) and relevant comorbid diseases (yes vs no), exact multiple logistic regression analysis indicated that only the presence of possible cardiac sources of emboli was associated with changes in by-products of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation </plain></SENT>
<SENT sid="3" pm="."><plain>If confirmed in a larger series of subjects, our results could have therapeutic implications, providing more support for the use of free radical scavengers in the <z:hpo ids='HP_0011009'>acute</z:hpo> care of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with a possible cardioembolic aetiology </plain></SENT>
</text></document>